Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02883673 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
A NA study of Postpartum Hemorrhage, sponsored by Alydia Health.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
- 15
- Study locations
NCT02883673: Completed NA study of Postpartum Hemorrhage, sponsored by Alydia Health.
NCT02883673 is a NA study of Postpartum Hemorrhage that has completed, run by Alydia Health. The registered enrollment target is 107 participants, below the 775-participant average among 19 other Postpartum Hemorrhage trials with a reported enrollment target (86% lower). The trial reports 15 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02883673, a NA study of Postpartum Hemorrhage, has completed, sponsored by Alydia Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
- 15
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the Jada System in the control and reduction of primary postpartum hemorrhage.
Primary Outcome
Control of postpartum hemorrhage, defined as the avoidance of non-surgical, second-line or surgical intervention to control uterine hemorrhage after the use of the Jada System per the Instructions for Use
Conditions Studied
Interventions
- DEVICE Jada System
Study Locations (15)
New York
- New York Presbyterian Queens - Flushing
- Nyph/Cumc - New York
Ohio
- MetroHealth Case Western - Cleveland
- The Ohio State University - Columbus
Pennsylvania
- Geisinger Medical Center - Danville
- UPMC - Magee Women's Hospital - Pittsburgh
Texas
- University of Texas Medical Branch - Galveston
- UT Health Science Center, McGovern School of Medicine - Houston
Alabama
- University of Alabama Birmingham - Birmingham
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Illinois
- Northwestern University - Chicago
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2017-09-17 |
| Est. Completion | 2020-03-25 |
| Phase | NA |
What the finished NCT02883673 record still lists
NCT02883673 is an interventional study that assigns participants to a tested intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, below the 775-participant average among 19 other Postpartum Hemorrhage trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Postpartum Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which Jada System is the first listed.
NCT02883673 lists 15 locations in 11 states (New York, Ohio, Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT02883673 about?
NCT02883673 is a clinical study titled "Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage". The purpose of this study is to evaluate the safety and effectiveness of the Jada System in the control and reduction of primary postpartum hemorrhage.
What is the current status of trial NCT02883673?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2017-09-17. Estimated completion is 2020-03-25.
What conditions does trial NCT02883673 study?
This clinical trial studies the following conditions: Postpartum Hemorrhage.
What interventions are being tested in trial NCT02883673?
The interventions under investigation include: Jada System (DEVICE).
Who is sponsoring clinical trial NCT02883673?
This trial is sponsored by Alydia Health, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02883673 being conducted?
This trial has 15 study locations across Alabama, District of Columbia, Illinois, Indiana, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02883673's enrollment target sits among peer trials
107 10th of 19 higher than 10 of 19 other Postpartum Hemorrhage trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postpartum Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage
RECRUITING · NA
-
A Pragmatic Randomized Controlled Trial to Predict Postpartum Hemorrhage
RECRUITING · NA
-
Postpartum Oxytocin Administration in the Era of Delayed Cord Clamping
COMPLETED · NA
-
Active Versus Expectant Management of the Third Stage of Labor
COMPLETED · NA
-
Implementation of the NPMS Obstetric Hemorrhage Bundle at a Tertiary Center: Utilization of the Delphi Method
COMPLETED · NA
-
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491668 · 107 participants
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
- NCT06041594 · 107 participants · NA
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- NCT06081426 · 107 participants · NA
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
- NCT06527599 · 107 participants · NA
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI